STOP THE WAR! Let’s support Ukraine Together

Health Sciences 2 (HSAQ) Shareholders Approve Orchestra BioMed Deal

orchestra

Health Sciences 2 (HSAQ) Shareholders Approve Orchestra BioMed Deal

Health Sciences 2 (NASDAQ:HSAQ) announced in an 8-K that its shareholders approved its combination with Orchestra BioMed at a special meeting yesterday.

The filing did not include redemption figures, but noted that about 87.2% of the SPAC’s outstanding shares participated in the vote, and all nine proposals were approved.

The parties expect to close the deal by the end of January and once completed, the combined company will trade on the Nasdaq under the symbol “OBIO”.

Health Sciences 2 announced its $158 million deal with Orchestra BioMed in July 2022. New Hope, Pennsylvania-based Orchestra BioMed develops evidence-based therapeutic solutions for medical procedures that address major medical conditions, with a particular focus on cardiovascular diseases.